
Susan Smyth
A Translational Researcher Herself, Was an Effective Leader and She Was Committed to Increase Excellence in Research at UAMS. · University of Arkansas for Medical Sciences (UAMS) College of Medicine
Credentials: · · · ·
History
- 1997–2000
Cardiovascular Disease
- 1994–1997
University Medical Center

Research
Platelet functions beyond hemostasis
Review · Journal of Thrombosis and Haemostasis · 2009 · First of 10 authors · Corresponding · 442 citations
Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity
Cell Metabolism · 2014 · 422 citations
Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis
Immunity · 2019 · 359 citations

25 papers

16 papers

11 papers

10 papers
- GO
10 papers · 10 as a fellow

10 papers
- SS
10 papers
- BC
9 papers
Grants
- 2020–2025
Serum Amyloid as a Critical Mediator Between Inflammation and Thrombosis
Department of Veterans Affairs · I01
Contact PI · Central Arkansas Veterans Hlthcare Sys
- 2021–2025
Lysophosphatidic Acid and Cardiovascular Disease Risk
Department of Veterans Affairs · I01
PI · Central Arkansas Veterans Hlthcare Sys
- 2016–2021
National Center for Advancing Translational Sciences · TL1
Contact PI · $2.2M · University of Kentucky
- 2015–2021
Lipid Phosphate Phosphatase 3 as a Novel Atherosclerosis Suppressor
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.1M · University of Kentucky
Clinical trials
- 2017–2021
The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis
Principal investigator · Withdrawn
Susan Smyth
- 2015
- 2015–2016
XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
Principal investigator · Terminated · Phase 4
Susan Smyth
- 2013–2016
Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
Principal investigator · Completed · Phase 1
University of Kentucky


